Physician profile
Derek D Reformat
NPI 1447578901
$5,002.16
in general payments reported to CMS, 2019-2025
15 companies · $1,086 in 2025
The $1,086 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,259 · 2020: $308 · 2021: $199 · 2022: $519 · 2023: $1,455 · 2024: $176 · 2025: $1,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $1,100 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $900 · Food and Beverage: $616 · Travel and Lodging: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $1,100.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $900.00 |
| Food and Beverage | $616.44 |
| Travel and Lodging | $100.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $1,100.00 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $969.76 | 2019-2023 | |
| W. L. Gore & Associates, INC. | $926.05 | 2019-2025 | Product In Development |
| Abbvie INC. | $378.03 | 2023-2025 | |
| Mentor Worldwide LLC | $378.02 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Tela Bio, INC. | $336.90 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sientra, INC. | $286.54 | 2019-2021 | |
| Smith+Nephew, INC. | $172.01 | 2020 | |
| Kerecis Limited | $143.53 | 2022 | |
| Aroa Biosurgery Incorporated | $131.28 | 2023 | |
| Allergan, INC. | $71.44 | 2021-2022 | |
| Derma Sciences, INC. | $39.31 | 2019 | |
| Misonix INC | $29.93 | 2019 | |
| Integra Lifesciences Corporation | $23.96 | 2020 | |
| Medtronic USA, INC. | $15.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Reformat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.